Talisman Wealth Advisors LLC Has $378,000 Stake in The Procter & Gamble Company (NYSE:PG)

Talisman Wealth Advisors LLC lifted its stake in shares of The Procter & Gamble Company (NYSE:PG) by 6.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,488 shares of the company’s stock after buying an additional 160 shares during the quarter. Talisman Wealth Advisors LLC’s holdings in Procter & Gamble were worth $378,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of PG. Bank Julius Baer & Co. Ltd Zurich grew its position in Procter & Gamble by 99,734.1% in the 2nd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 253,081,478 shares of the company’s stock valued at $38,402,583,000 after purchasing an additional 252,827,976 shares during the period. Moneta Group Investment Advisors LLC grew its position in Procter & Gamble by 96,526.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 38,535,557 shares of the company’s stock valued at $5,840,449,000 after purchasing an additional 38,495,676 shares during the period. Norges Bank acquired a new stake in Procter & Gamble in the 4th quarter valued at $3,752,321,000. Price T Rowe Associates Inc. MD grew its position in Procter & Gamble by 42.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 24,386,838 shares of the company’s stock valued at $3,626,080,000 after purchasing an additional 7,235,990 shares during the period. Finally, Morgan Stanley grew its position in Procter & Gamble by 12.6% in the 4th quarter. Morgan Stanley now owns 44,320,700 shares of the company’s stock valued at $6,717,246,000 after purchasing an additional 4,959,527 shares during the period. Institutional investors and hedge funds own 63.43% of the company’s stock.

Procter & Gamble Stock Performance

Procter & Gamble stock traded down $1.76 during midday trading on Friday, reaching $151.07. The stock had a trading volume of 8,495,710 shares, compared to its average volume of 6,541,199. The Procter & Gamble Company has a 12 month low of $135.83 and a 12 month high of $158.38. The firm’s 50-day moving average price is $149.28 and its 200 day moving average price is $150.69. The firm has a market capitalization of $356.06 billion, a PE ratio of 24.52, a P/E/G ratio of 3.16 and a beta of 0.47. The company has a quick ratio of 0.48, a current ratio of 0.67 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Wednesday, October 18th. The company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.12. Procter & Gamble had a return on equity of 33.49% and a net margin of 18.30%. The business had revenue of $21.87 billion for the quarter, compared to analysts’ expectations of $21.58 billion. During the same period in the previous year, the business posted $1.57 EPS. The firm’s quarterly revenue was up 6.1% compared to the same quarter last year. As a group, research analysts predict that The Procter & Gamble Company will post 6.42 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Friday, October 20th were given a dividend of $0.9407 per share. This represents a $3.76 annualized dividend and a dividend yield of 2.49%. The ex-dividend date was Thursday, October 19th. Procter & Gamble’s dividend payout ratio is presently 61.04%.

Insider Activity

In other news, CFO Andre Schulten sold 40,298 shares of the company’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $150.61, for a total transaction of $6,069,281.78. Following the sale, the chief financial officer now directly owns 36,460 shares in the company, valued at $5,491,240.60. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, CAO Matthew W. Janzaruk sold 188 shares of the business’s stock in a transaction dated Friday, October 20th. The stock was sold at an average price of $148.52, for a total transaction of $27,921.76. Following the completion of the transaction, the chief accounting officer now owns 626 shares of the company’s stock, valued at $92,973.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 40,298 shares of the business’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $150.61, for a total value of $6,069,281.78. Following the transaction, the chief financial officer now directly owns 36,460 shares of the company’s stock, valued at approximately $5,491,240.60. The disclosure for this sale can be found here. Insiders have sold a total of 96,088 shares of company stock worth $14,565,908 over the last ninety days. Company insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on PG. Jefferies Financial Group began coverage on shares of Procter & Gamble in a research report on Monday, November 13th. They issued a “buy” rating and a $177.00 price target for the company. JPMorgan Chase & Co. cut their price objective on shares of Procter & Gamble from $172.00 to $169.00 and set an “overweight” rating on the stock in a report on Thursday, October 12th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Procter & Gamble from $170.00 to $173.00 and gave the stock a “buy” rating in a report on Monday, July 31st. Royal Bank of Canada lifted their price objective on shares of Procter & Gamble from $165.00 to $167.00 and gave the stock a “sector perform” rating in a report on Monday, July 31st. Finally, HSBC started coverage on shares of Procter & Gamble in a report on Friday, September 22nd. They set a “buy” rating and a $179.00 price objective on the stock. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $165.83.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.